Leading financial institutions are bullish on select Indian stocks. HSBC recommends Dr Reddy’s Labs for its semaglutide prospects, while Goldman Sachs sees strong growth for Titan’s jewellery and other ventures. Bernstein is optimistic about Trent’s recovery, and CLSA highlights Power Grid Corp’s strategic entry into battery storage. ITC faces potential tax uncertainty.